Zogenix Reports Granting of Inducement Awards Under Nasdaq

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
55
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

EMERYVILLE, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it has issued an inducement award to Ashish Sagrolikar, the company’s newly appointed Executive Vice President and Chief Commercial Officer, and additional inducement awards to three new non-executive employees. 

The awards were made on July 2, 2018 under Zogenix’s Employment Inducement Equity Incentive Award Plan, which provides for the granting of equity awards to new employees of Zogenix as an inducement to join the company. Mr. Sagrolikar was granted inducement awards consisting of options to purchase 100,000 shares of Zogenix common stock and 15,000 restricted stock units. The inducement awards to the three new non-executive employees consist of options to purchase an aggregate of 28,000 shares of Zogenix common stock. The options have a ten-year term and an exercise price equal to $43.70, the fair market value of Zogenix common stock on the date of grant. The options vest over a four-year period, with 25% of the options vesting on the first anniversary of each employee’s respective start date and the remainder vesting in equal monthly installments over the three years thereafter. The restricted stock units granted to Mr. Sagrolikar vest in four equal installments on each of the first four anniversaries of the date of grant. The awards were approved by the independent compensation committee of Zogenix’s board of directors and were granted as an inducement material to the new employees entering into employment with Zogenix in accordance with Nasdaq Marketplace Rule 5635(c)(4).

About Zogenix

Zogenix (Nasdaq: ZGNX ) is focused on developing therapies for patients with rare central nervous system (CNS) conditions that have limited or no treatment options but face a critical need. For more information, visit www.zogenix.com .

CONTACT:

Investors: Andrew McDonald Founding Partner, LifeSci Advisors LLC 646-597-6987 | Andrew@lifesciadvisors.com

Media: David Polk Senior Media Relations Strategist, Syneos Health 310-309-1029 | david.polk@syneoshealth.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 2

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 2

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 2

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 4

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Dylan Media Challenges CLIQ Digital's Proposed Share Buyback

Updated Category News Views 176

CLIQ Digital AG Faces Critical Vote from Major Shareholder CLIQ Digital AG, a well-known entity in the digital services industry, recently found itself at a pivotal moment. Dylan Media B.V., the largest shareholder in CLIQ Digital, has made headlines by declaring its intent to vote against a significant item on the agenda at the upcoming Annual General Meeting. This...

Continue Reading
CW Bancorp Announces Quarterly Dividend for Shareholders

Updated Category News Views 213

CW Bancorp Declares a Refreshing Quarterly Dividend CW BANCORP (OTCQX: CWBK), the parent company of CommerceWest Bank, recently announced the approval of a quarterly cash dividend by its Board of Directors. This step signifies the company's ongoing dedication to maximizing shareholder value. The Board declared a cash dividend of $0.23 per common share, illustrating the...

Continue Reading
Celebrating 5 Years: Legacy Leaders at HBCU ELI Shine Bright

Updated Category News Views 209

HBCU Executive Leadership Institute: Five Years of Excellence The HBCU Executive Leadership Institute at Clark Atlanta University has reached a significant milestone, celebrating its fifth anniversary. This program is dedicated to nurturing and developing the next generation of presidents and executives at Historically Black Colleges and Universities (HBCUs). It is an...

Continue Reading
Kuehn Law Investigates StubHub Holdings for Shareholder Rights

Updated Category News Views 103

Kuehn Law Investigates StubHub Holdings for Shareholder Rights NEW YORK – Kuehn Law, PLLC, a law firm dedicated to shareholder litigation, is focused on examining whether certain officers and directors at StubHub Holdings, Inc. (NYSE: STUB) have acted against the interests of shareholders. The firm’s investigation is driven by allegations in a federal securities...

Continue Reading
A Comprehensive Guide to Hard Money Lenders in Real Estate Financing

Updated Category Real Estate Views 690

In real estate financing, money lenders occupy a distinctive niche. They offer alternative funding solutions that diverge from traditional banking institutions. A hard money lender presents a viable option for those seeking quick access to capital or needing help securing loans through conventional means. Comprehending the nuances of this financing avenue is paramount...

Continue Reading